SCHEMBL30429239

SCHEMBL30429239

C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.62
▸ OPRD1 P41143 6/20 0.55
▸ OPRM1 P35372 5/20 0.55
▸ OPRK1 P41145 2/20 0.55
▸ NPY5R Q15761 3/20 0.53
▸ NPY1R P25929 2/20 0.53
▸ NPY4R P50391 2/20 0.53
▸ KISS1R Q969F8 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30310937 0.93 TFPI (0.58) TFPIOPRD1OPRM1OPRK1NPY5R
SCHEMBL30900790 0.92 TFPI (0.65) TFPIOPRD1OPRM1OPRK1
SCHEMBL30900782 0.92 TFPI (0.65) TFPIOPRD1OPRM1OPRK1
SCHEMBL30350874 0.91 TFPI (0.55) TFPIOPRD1OPRM1OPRK1NPY5R
SCHEMBL30562995 0.91 TFPI (0.55) TFPIOPRD1OPRM1OPRK1NPY5R
SCHEMBL30942326 0.89 OPRD1 (0.64) TFPIOPRD1OPRM1OPRK1NPY5R
SCHEMBL30310794 0.89 TFPI (0.62) TFPINPY5RNPY1RNPY4R
SCHEMBL31121317 0.89 TFPI (0.60) TFPIOPRD1OPRM1OPRK1NPY5R
SCHEMBL29679886 0.89 NPY5R (0.56) TFPIOPRD1OPRM1OPRK1NPY5R
SCHEMBL31141451 0.89 TFPI (0.65) TFPIOPRD1OPRM1OPRK1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165951-A1 Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 MAMEDOV TARLAN (TR) 2023-06-01 — — US disclosed
Send feedback